Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

5 Ideas To Improve Device Cybersecurity

Executive Summary

US FDA officials recently teamed with government contractors to interview hospitals, device manufacturers and cybersecurity experts about key device cybersecurity challenges and possible solutions. Here are five key takeaways from the project.

You may also be interested in...



US FDA Pushes Further On Cybersecurity Efforts Despite Limited Resources

US FDA unveiled multiple cybersecurity-related initiatives, including two memoranda of understandings to launch information sharing organizations and playbook for health-care delivery organizations. The agency is continuing a multi-front attack in the area, despite limited resources.

Message To US Congress: Know What Cybersecurity Tools You Have, Share What You Know, Untie Our Hands

Responding to US lawmakers on how to tackle cybersecurity threats to medical devices and the health-care system, device firms, hospitals, provider groups and other stakeholders listed recommendations on creating inventories, sharing information and amending laws.

US Congress Asks For Input On Fighting Medtech Cybersecurity Threats

The House Energy and Commerce Committee is asking stakeholders to help prevent cyberattacks on medical devices and systems, citing recent attacks. One key issue cited by the committee: simply asking companies to update legacy devices or switching out those devices for newer ones is unfeasible.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel